|
|
Blood, 15 August 2005, Vol. 106, No. 4, pp. 1460-1465.
Prepublished online as a Blood First Edition Paper on April 28, 2005; DOI 10.1182/blood-2004-10-3982.
Previous Article | Table of Contents | Next Article 
RED CELLS
MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients
John C. Wood,
Cathleen Enriquez,
Nilesh Ghugre,
J. Michael Tyzka,
Susan Carson,
Marvin D. Nelson, and
Thomas D. Coates
From the Department of Pediatrics and the Department of Radiology, Children's Hospital of Los Angeles, CA; and the Department of Biology, California Institute of Technology, Pasadena, CA.
Measurements of hepatic iron concentration (HIC) are important predictors of transfusional iron burden and long-term outcome in patients with transfusion-dependent anemias. The goal of this work was to develop a readily available, noninvasive method for clinical HIC measurement. The relaxation rates R2 (1/T2) and R2* (1/T2*) measured by magnetic resonance imaging (MRI) have different advantages for HIC estimation. This article compares noninvasive iron estimates using both optimized R2 and R2* methods in 102 patients with iron overload and 13 controls. In the iron-overloaded group, 22 patients had concurrent liver biopsy. R2 and R2* correlated closely with HIC (r2 .95) for HICs between 1.33 and 32.9 mg/g, but R2 had a curvilinear relationship to HIC. Of importance, the R2 calibration curve was similar to the curve generated by other researchers, despite significant differences in technique and instrumentation. Combined R2 and R2* measurements did not yield more accurate results than either alone. Both R2 and R2* can accurately measure hepatic iron concentration throughout the clinically relevant range of HIC with appropriate MRI acquisition techniques. (Blood. 2005;106:1460-1465)

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. J. Noetzli, J. Papudesi, T. D. Coates, and J. C. Wood
Pancreatic iron loading predicts cardiac iron loading in thalassemia major
Blood,
November 5, 2009;
114(19):
4021 - 4026.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Chandarana, R. P. Lim, J. H. Jensen, C. H. Hajdu, M. Losada, J. S. Babb, S. Huffman, and B. Taouli
Hepatic Iron Deposition in Patients With Liver Disease: Preliminary Experience With Breath-Hold Multiecho T2*-Weighted Sequence
Am. J. Roentgenol.,
November 1, 2009;
193(5):
1261 - 1267.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Taouli, R. L. Ehman, and S. B. Reeder
Advanced MRI Methods for Assessment of Chronic Liver Disease
Am. J. Roentgenol.,
July 1, 2009;
193(1):
14 - 27.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Hankins, M. B. McCarville, R. B. Loeffler, M. P. Smeltzer, M. Onciu, F. A. Hoffer, C.-S. Li, W. C. Wang, R. E. Ware, and C. M. Hillenbrand
R2* magnetic resonance imaging of the liver in patients with iron overload
Blood,
May 14, 2009;
113(20):
4853 - 4855.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Nick, P. R. Allegrini, L. Fozard, U. Junker, L. Rojkjaer, R. Salie, V. Niederkofler, and T. O'Reilly
Deferasirox Reduces Iron Overload in a Murine Model of Juvenile Hemochromatosis
Experimental Biology and Medicine,
May 1, 2009;
234(5):
492 - 503.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. J. Noetzli, S. M. Carson, A. S. Nord, T. D. Coates, and J. C. Wood
Longitudinal analysis of heart and liver iron in thalassemia major
Blood,
October 1, 2008;
112(7):
2973 - 2978.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Leonardi, R. Margossian, S. D. Colan, and A. J. Powell
Relationship of magnetic resonance imaging estimation of myocardial iron to left ventricular systolic and diastolic function in thalassemia.
J. Am. Coll. Cardiol. Img.,
September 1, 2008;
1(5):
572 - 578.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Wood, R. Origa, A. Agus, G. Matta, T. D. Coates, and R. Galanello
Onset of cardiac iron loading in pediatric patients with thalassemia major
Haematologica,
June 1, 2008;
93(6):
917 - 920.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Angelucci, G. Barosi, C. Camaschella, M. D. Cappellini, M. Cazzola, R. Galanello, M. Marchetti, A. Piga, and S. Tura
Italian Society of Hematology practice guidelines for the management of iron overload in thalassemia major and related disorders
Haematologica,
May 1, 2008;
93(5):
741 - 752.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. P. O'Regan, M. F. Callaghan, M. Wylezinska-Arridge, J. Fitzpatrick, R. P. Naoumova, J. V. Hajnal, and S. A. Schmitz
Liver Fat Content and T2*: Simultaneous Measurement by Using Breath-hold Multiecho MR Imaging at 3.0 T--Feasibility
Radiology,
May 1, 2008;
247(2):
550 - 557.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Pennell, V. Berdoukas, M. Karagiorga, V. Ladis, A. Piga, A. Aessopos, E. D. Gotsis, M. A. Tanner, G. C. Smith, M. A. Westwood, et al.
Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis
Blood,
May 1, 2006;
107(9):
3738 - 3744.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|